StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
693
This month
6
This week
1
This year
39
Publishing Date
2023 - 12 - 08
4
2023 - 10 - 15
3
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 30
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 09
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 11 - 02
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
4
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
4
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2021 - 01 - 08
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
2
Sector
Commercial services
3
Communications
30
Consumer durables
3
Consumer non-durables
7
Consumer services
1
Distribution services
2
Electronic technology
6
Finance
11
Health services
3
Health technology
693
Industrial services
2
Manufacturing
44
N/a
14
Process industries
7
Producer manufacturing
3
Professional, scientific, and technical services
11
Retail trade
2
Technology services
4
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
34
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
74
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1797
Abbvie inc.
1030
Accenture plc
602
Alphabet inc.
1304
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4319
Astrazeneca plc
668
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1768
Boston scientific corporation
577
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1711
Ericsson
1617
Extreme networks, inc.
581
First bank
602
Ford motor company
643
Gartner, inc.
595
General electric company
919
Glaxosmithkline plc
888
Honeywell international inc.
1792
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
657
Johnson & johnson
4606
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
973
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1205
Morgan stanley
4298
Nokia corp
993
Nokia corporation
917
Northrop grumman corporation
590
Novartis ag
1245
Novo nordisk a/s
636
Oracle corporation
1161
Orange
7229
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4559
Sap se
1481
Snowflake inc.
796
Stellantis n.v
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1630
Verizon communications inc.
1223
X financial
678
Symbols
ABBV
37
ABT
32
ADCT
5
AERI
5
AGIO
10
ALKS
4
ALNY
14
ALPMF
26
ALPMY
26
AMGN
34
ARVN
24
AVEO
10
AZN
45
AZNCF
35
BAX
6
BCRX
14
BDX
6
BEAM
6
BGNE
10
BHC
5
BHVN
15
BMY
61
BNTX
95
BPMC
10
CLVS
11
ENDP
7
EPZM
11
EXEL
13
FNCTF
29
GBT
6
GILD
27
GLAXF
42
GSK
64
ILMN
12
INCY
14
IONS
5
JNJ
76
KPTI
10
LLY
80
MRNA
7
MYOV
14
NVO
11
NVS
88
NVSEF
68
OMER
13
OPK
6
OTIC
13
PFE
693
REGN
22
RIGL
11
SGEN
7
SNY
153
SNYNF
90
TAK
23
TEVJF
29
VSTM
10
VTRS
8
VYGR
6
XERS
10
YMAB
10
Exchanges
Amex
5
Nasdaq
423
Nyse
693
Crawled Date
2024 - 02 - 27
3
2023 - 12 - 08
4
2023 - 10 - 16
5
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
3
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
3
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 04 - 13
3
2021 - 04 - 01
2
2021 - 03 - 31
2
2021 - 03 - 26
2
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
3
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
39
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
ir.akerotx.com
2
ir.vaccinex.com
1
ir.voyagertherapeutics.com
3
mindmed.co
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
261
www.chi-med.com
1
www.eyenoviabio.com
1
www.fda.gov
31
www.globenewswire.com
147
www.prnewswire.com
242
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Pfizer, inc.
save search
FDA Roundup: August 15, 2023
Published:
2023-08-15
(Crawled : 20:00)
- fda.gov
FNCTF
|
News
|
$11.16
-20.84%
130
|
Communications
|
-0.71%
|
O:
1.51%
H:
0.0%
C:
-1.03%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-25.63%
|
O:
-0.71%
H:
1.45%
C:
0.97%
fda
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published:
2023-08-09
(Crawled : 13:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.15%
|
O:
-0.11%
H:
1.29%
C:
0.67%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-19.96%
|
O:
0.08%
H:
2.08%
C:
1.3%
DCPH
|
$14.6
-0.48%
-0.48%
320K
|
Health Technology
|
13.37%
|
O:
4.95%
H:
2.5%
C:
1.18%
pharmaceuticals
financial
results
North America Kidney Transplant Research Report 2023
Published:
2023-08-08
(Crawled : 22:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-36.78%
|
O:
3.93%
H:
0.0%
C:
-3.08%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.15%
|
O:
-0.11%
H:
1.29%
C:
0.67%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.07%
|
O:
-0.07%
H:
0.73%
C:
0.36%
MDT
|
$80.38
-1.12%
0.0%
5M
|
Health Technology
|
-3.15%
|
O:
-1.98%
H:
1.7%
C:
0.81%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.87%
|
O:
0.81%
H:
0.0%
C:
0.0%
america
report
kidney
research
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-08-08
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.23%
|
O:
1.93%
H:
0.0%
C:
-2.01%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
42.74%
|
O:
1.09%
H:
1.29%
C:
0.91%
update
financial
results
Women's Health Global Marketplace 2023-2030: Endometriosis Applications Poised for Remarkable Expansion with Relugoliz and Linzagolix Set to Lead the Way
Published:
2023-08-04
(Crawled : 19:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
health
expansion
global
linzagolix
set
Pfizer Reports Second-Quarter 2023 Results
Published:
2023-08-01
(Crawled : 12:00)
- biospace.com/
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
1.65%
|
O:
-1.8%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.08%
|
O:
-0.48%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-17.6%
|
O:
1.14%
H:
0.0%
C:
-1.36%
results
Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer
Published:
2023-07-31
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.08%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
37.54%
|
O:
-0.73%
H:
2.32%
C:
1.3%
protac
breast
innovation
cancer
group
designation
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
Published:
2023-07-27
(Crawled : 14:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-29.27%
|
O:
-1.16%
H:
0.0%
C:
0.0%
research
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
Published:
2023-07-21
(Crawled : 21:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-28.42%
|
O:
0.08%
H:
1.71%
C:
1.63%
Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
Published:
2023-07-19
(Crawled : 22:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.37%
|
O:
0.28%
H:
0.99%
C:
0.28%
candidate
vaccine
publication
group
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Published:
2023-07-06
(Crawled : 14:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.81%
|
O:
-0.71%
H:
0.19%
C:
-1.57%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
37.48%
|
O:
-2.06%
H:
0.0%
C:
-3.96%
collaboration
trial
therapeutics
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
Published:
2023-07-06
(Crawled : 12:00)
- globenewswire.com
CRBU
|
$3.86
-3.02%
-3.11%
1.1M
|
Health Technology
|
-2.45%
|
O:
37.25%
H:
22.86%
C:
6.07%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.81%
|
O:
-0.71%
H:
0.19%
C:
-1.57%
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$24.66
1.65%
1.62%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$128.725
-39.66%
750
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Published:
2023-06-28
(Crawled : 11:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.73%
|
O:
0.22%
H:
0.11%
C:
-0.58%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-24.7%
|
O:
24.1%
H:
0.97%
C:
-16.5%
fda
treatment
growth
hormone
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
Published:
2023-06-27
(Crawled : 12:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-28.65%
|
O:
0.19%
H:
0.11%
C:
-1.46%
fda
application
therapy
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
7.57%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-15.38%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-28.65%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.65%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.54%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
13.7%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
63.23%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.39%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-1.23%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
Published:
2023-06-26
(Crawled : 12:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-31.28%
|
O:
-3.36%
H:
0.09%
C:
-0.34%
obesity
update
program
diabetes
Pfizer Declares Third-Quarter 2023 Dividend
Published:
2023-06-22
(Crawled : 11:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.34%
|
O:
0.1%
H:
0.12%
C:
-0.54%
Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published:
2023-06-16
(Crawled : 02:00)
- prnewswire.com
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
40.25%
|
O:
1.21%
H:
0.0%
C:
-0.2%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-33.79%
|
O:
0.28%
H:
1.25%
C:
0.5%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.59%
|
O:
0.46%
H:
0.31%
C:
-0.15%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
62.81%
|
O:
0.41%
H:
0.26%
C:
-1.77%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.25%
|
O:
0.32%
H:
2.1%
C:
1.97%
approved
treatment
global
market
Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published:
2023-06-15
(Crawled : 10:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-33.13%
|
O:
0.13%
H:
1.07%
C:
0.86%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.82%
|
O:
1.04%
H:
0.78%
C:
0.67%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
65.07%
|
O:
0.06%
H:
1.91%
C:
1.32%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
23.06%
|
O:
0.33%
H:
2.62%
C:
2.43%
market
← Previous
1
2
3
4
5
6
7
8
9
10
…
34
35
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.